{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:37:38Z","timestamp":1794605858834,"version":"4.9.1"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1212\/con.0000000000000300","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T13:15:42Z","timestamp":1461071742000},"page":"464-489","source":"Crossref","is-referenced-by-count":81,"title":["Frontotemporal Dementias"],"prefix":"10.1212","volume":"22","author":[{"given":"Elizabeth C.","family":"Finger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","unstructured":"Knopman DS Roberts RO. Estimating the number of persons with frontotemporal lobar degeneration in the US population. J Mol Neurosci 2011; 45(3): 330\u2013335. doi:10.1007\/s12031-011-9538-y.","DOI":"10.1007\/s12031-011-9538-y"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","unstructured":"Onyike CU Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int Rev Psychiatry 2013; 25(2): 130\u2013137. doi:10.3109\/09540261.2013.776523.","DOI":"10.3109\/09540261.2013.776523"},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","unstructured":"Snowden JS Thompson JC Stopford CL et al. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain 2011; 134(pt 9): 2478\u20132492. doi:10.1093\/brain\/awr189.","DOI":"10.1093\/brain\/awr189"},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","unstructured":"Rascovsky K Hodges JR Knopman D et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134(pt 9): 2456\u20132477. doi:10.1093\/brain\/awr179.","DOI":"10.1093\/brain\/awr179"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","unstructured":"Snowden JS Rollinson S Thompson JC et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 2012; 135(pt 3): 693\u2013708. doi:10.1093\/brain\/awr355.","DOI":"10.1093\/brain\/awr355"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","unstructured":"Links KA Merims D Binns MA et al. Prevalence of primitive reflexes and Parkinsonian signs in dementia. Can J Neurol Sci 2010; 37(5): 601\u2013607. doi:10.1017\/S0317167100010763.","DOI":"10.1017\/S0317167100010763"},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","unstructured":"Pennington C Hodges JR Hornberger M. Neural correlates of episodic memory in behavioral variant frontotemporal dementia. J Alzheimers Dis 2011; 24(2): 261\u2013268. doi:10.3233\/JAD-2011-101668.","DOI":"10.3233\/JAD-2011-101668"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","unstructured":"Manoochehri M Huey ED. Diagnosis and management of behavioral issues in frontotemporal dementia. Curr Neurol Neurosci Rep 2012; 12(5): 528\u2013536. doi:10.1007\/s11910-012-0302-7.","DOI":"10.1007\/s11910-012-0302-7"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","unstructured":"Rohrer JD Nicholas JM Cash DM et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol 2015; 14(3): 253\u2013262. doi:10.1016\/S1474-4422(14)70324-2.","DOI":"10.1016\/S1474-4422(14)70324-2"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","unstructured":"Whitwell JL Weigand SD Boeve BF et al. Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72 tau progranulin and sporadics. Brain 2012; 135(pt 3): 794\u2013806. doi:10.1093\/brain\/aws001.","DOI":"10.1093\/brain\/aws001"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","unstructured":"Rabinovici GD Rosen HJ Alkalay A et al. Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD. Neurology 2011; 77(23): 2034\u20132042. doi:10.1212\/WNL.0b013e31823b9c5e.","DOI":"10.1212\/WNL.0b013e31823b9c5e"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","unstructured":"McNeill R Sare GM Manoharan M et al. Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 2007; 78(4): 350\u2013355. doi:10.1136\/jnnp.2006.106054.","DOI":"10.1136\/jnnp.2006.106054"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","unstructured":"Foster NL Heidebrink JL Clark CM et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer\u2019s disease. Brain 2007; 130(pt 10): 2616\u20132635. doi:10.1093\/brain\/awm177.","DOI":"10.1093\/brain\/awm177"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","unstructured":"Chow TW Binns MA Freedman M et al. Overlap in frontotemporal atrophy between normal aging and patients with frontotemporal dementias. Alzheimer Dis Assoc Disord 2008; 22(4): 327\u2013335. doi:10.1097\/WAD.0b013e31818026c4.","DOI":"10.1097\/WAD.0b013e31818026c4"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","unstructured":"Hornberger M Shelley BP Kipps CM et al. Can progressive and non-progressive behavioural variant frontotemporal dementia be distinguished at presentation? J Neurol Neurosurg Psychiatry 2009; 80(6): 591\u2013593. doi:10.1136\/jnnp.2008.163873.","DOI":"10.1136\/jnnp.2008.163873"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","unstructured":"Gossink FT Dols A Kerssens CJ et al. Psychiatric diagnoses underlying the phenocopy syndrome of behavioural variant frontotemporal dementia. J Neurol Neurosurg Psychiatry 2016; 87(1): 64\u201368. doi:10.1136\/jnnp-2014-308284.","DOI":"10.1136\/jnnp-2014-308284"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","unstructured":"Miller BL. Frontotemporal dementia. New York: Oxford University Press 2014.","DOI":"10.1093\/med\/9780195380491.001.0001"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","unstructured":"Gorno-Tempini ML Hillis AE Weintraub S et al. Classification of primary progressive aphasia and its variants. Neurology 2011; 76(100): 1006\u20131014. doi:10.1212\/WNL.0b013e31821103e6.","DOI":"10.1212\/WNL.0b013e31821103e6"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","unstructured":"Rankin KP Gorno-Tempini ML Allison SC et al. Structural anatomy of empathy in neurodegenerative disease. Brain 2006; 129(pt 11): 2945\u20132956. doi:10.1093\/brain\/awl254.","DOI":"10.1093\/brain\/awl254"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","unstructured":"Kamminga J Kumfor F Burrell JR et al. Differentiating between right-lateralised semantic dementia and behavioural-variant frontotemporal dementia: an examination of clinical characteristics and emotion processing. J Neurol Neurosurg Psychiatry 2015; 86(10): 1082\u20131088. doi:10.1136\/jnnp-2014-309120.","DOI":"10.1136\/jnnp-2014-309120"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","unstructured":"McCarthy RA Warrington EK. Past present and prospects: reflections 40 years on from the selective impairment of semantic memory (Warrington 1975). Q J Exp Psychol (Hove) 2015: 1\u201328. doi:10.1080\/17470218.2014.980280.","DOI":"10.1080\/17470218.2014.980280"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","unstructured":"Rohrer JD Rosen HJ. Neuroimaging in frontotemporal dementia. Int Rev Psychiatry 2013; 25(2): 221\u2013229. doi:10.3109\/09540261.2013.778822.","DOI":"10.3109\/09540261.2013.778822"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","unstructured":"Josephs KA Boeve BF Duffy JR et al. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase 2005; 11(4): 283\u2013296. doi:10.1080\/13554790590963004.","DOI":"10.1080\/13554790590963004"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","unstructured":"Litvan I Agid Y Calne D et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47(1): 1\u20139. doi:10.1212\/WNL.47.1.1.","DOI":"10.1212\/WNL.47.1.1"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","unstructured":"Kobylecki C Jones M Thompson JC et al. Cognitive-behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia. J Neurol 2015; 262(4): 916\u2013922. doi:10.1007\/s00415-015-7657-z.","DOI":"10.1007\/s00415-015-7657-z"},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","unstructured":"Josephs KA Duffy JR Strand EA et al. Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech. Brain 2012; 135(pt 5): 1522\u20131536. doi:10.1093\/brain\/aws032.","DOI":"10.1093\/brain\/aws032"},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","unstructured":"Boeve BF. Progressive supranuclear palsy. Parkinsonism Relat Disord 2012; 18(suppl 1): S192\u2013S194. doi:10.1016\/S1353-8020(11)70060-8.","DOI":"10.1016\/S1353-8020(11)70060-8"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","unstructured":"Zalewski N Botha H Whitwell JL et al. FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants. J Neurol 2014; 261(4): 710\u2013716. doi:10.1007\/s00415-014-7256-4.","DOI":"10.1007\/s00415-014-7256-4"},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","unstructured":"Armstrong MJ Litvan I Lang AE et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013; 80(5): 496\u2013503. doi:10.1212\/WNL.0b013e31827f0fd1.","DOI":"10.1212\/WNL.0b013e31827f0fd1"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","unstructured":"Murray R Neumann M Forman MS et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology 2007; 68(16): 1274\u20131283. doi:10.1212\/01.wnl.0000259519.78480.c3.","DOI":"10.1212\/01.wnl.0000259519.78480.c3"},{"key":"e_1_3_1_34_2","doi-asserted-by":"crossref","unstructured":"Whitwell JL Jack CR Jr Boeve BF et al. Imaging correlates of pathology in corticobasal syndrome. Neurology 2010; 75(21): 1879\u20131887. doi:10.1212\/WNL.0b013e3181feb2e8.","DOI":"10.1212\/WNL.0b013e3181feb2e8"},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","unstructured":"Strong MJ Grace GM Freedman M et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009; 10(3): 131\u2013146. doi:10.1080\/17482960802654364.","DOI":"10.1080\/17482960802654364"},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","unstructured":"Renton AE Majounie E Waite A et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72(2): 257\u2013268. doi:10.1016\/j.neuron.2011.09.010.","DOI":"10.1016\/j.neuron.2011.09.010"},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","unstructured":"DeJesus-Hernandez M Mackenzie IR Boeve BF et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011; 72(2): 245\u2013256. doi:10.1016\/j.neuron.2011.09.011.","DOI":"10.1016\/j.neuron.2011.09.011"},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","unstructured":"Rosso SM Landweer EJ Houterman M et al. Medical and environmental risk factors for sporadic frontotemporal dementia: a retrospective case-control study. J Neurol Neurosurg Psychiatry 2003; 74(11): 1574\u20131576. doi:10.1136\/jnnp.74.11.1574.","DOI":"10.1136\/jnnp.74.11.1574"},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","unstructured":"Kalkonde YV Jawaid A Qureshi SU et al. Medical and environmental risk factors associated with frontotemporal dementia: a case-control study in a veteran population. Alzheimers Dement 2012; 8(3): 204\u2013210. doi:10.1016\/j.jalz.2011.03.011.","DOI":"10.1016\/j.jalz.2011.03.011"},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","unstructured":"Stern RA Daneshvar DH Baugh CM et al. Clinical presentation of chronic traumatic encephalopathy. Neurology 2013; 81(13): 1122\u20131129. doi:10.1212\/WNL.0b013e3182a55f7f.","DOI":"10.1212\/WNL.0b013e3182a55f7f"},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","unstructured":"Rohrer JD Guerreiro R Vandrovcova J et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology 2009; 73(18): 1451\u20131456. doi:10.1212\/WNL.0b013e3181bf997a.","DOI":"10.1212\/WNL.0b013e3181bf997a"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","unstructured":"Le Ber I. Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm. Rev Neurol (Paris) 2013; 169(10): 811\u2013819. doi:10.1016\/j.neurol.2013.07.014.","DOI":"10.1016\/j.neurol.2013.07.014"},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","unstructured":"Cruts M Gijselinck I van der Zee J et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006; 442(7105): 920\u2013924. doi:10.1038\/nature05017.","DOI":"10.1038\/nature05017"},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","unstructured":"Hutton M Lendon CL Rizzu P et al. Association of missense and 5\u2019-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393(6686): 702\u2013705. doi:10.1038\/31508.","DOI":"10.1038\/31508"},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","unstructured":"Watts GD Wymer J Kovach MJ et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004; 36(4): 377\u2013381. doi:10.1038\/ng1332.","DOI":"10.1038\/ng1332"},{"key":"e_1_3_1_46_2","doi-asserted-by":"crossref","unstructured":"Benajiba L Le Ber I Camuzat A et al. TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 2009; 65(4): 470\u2013473. doi:10.1002\/ana.21612.","DOI":"10.1002\/ana.21612"},{"key":"e_1_3_1_47_2","doi-asserted-by":"crossref","unstructured":"Broustal O Camuzat A Guillot-No\u00ebl L et al. FUS mutations in frontotemporal lobar degeneration with amyotrophic lateral sclerosis. J Alzheimers Dis 2010; 22(3): 765\u2013769. doi:10.3233\/JAD-2010-100837.","DOI":"10.3233\/JAD-2010-100837"},{"key":"e_1_3_1_48_2","doi-asserted-by":"crossref","unstructured":"Fecto F Yan J Vemula SP et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 2011; 68(11): 1440\u20131446. doi:10.1001\/archneurol.2011.250.","DOI":"10.1001\/archneurol.2011.250"},{"key":"e_1_3_1_49_2","doi-asserted-by":"crossref","unstructured":"Rubino E Rainero I Chi\u00f2 A et al. SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology 2012; 79(15): 1556\u20131562. doi:10.1212\/WNL.0b013e31826e25df.","DOI":"10.1212\/WNL.0b013e31826e25df"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","unstructured":"Rademakers R Baker M Nicholson AM et al. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet 2011; 44(2): 200\u2013205. doi:10.1038\/ng.1027.","DOI":"10.1038\/ng.1027"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","unstructured":"Guerreiro R Kara E Le Ber I et al. Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene. JAMA Neurol 2013; 70(7): 875\u2013882. doi:10.1001\/jamaneurol.2013.698.","DOI":"10.1001\/jamaneurol.2013.698"},{"key":"e_1_3_1_52_2","doi-asserted-by":"crossref","unstructured":"Skibinski G Parkinson NJ Brown JM et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005; 37(8): 806\u2013808. doi:10.1038\/ng1609.","DOI":"10.1038\/ng1609"},{"key":"e_1_3_1_53_2","doi-asserted-by":"crossref","unstructured":"Gellera C Tiloca C Del Bo R et al.; SLAGEN Consortium. Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. J Neurol Neurosurg Psychiatry 2013; 84(2): 183\u2013187. doi:10.1136\/jnnp-2012-303433.","DOI":"10.1136\/jnnp-2012-303433"},{"key":"e_1_3_1_54_2","doi-asserted-by":"crossref","unstructured":"Kim HJ Kim NC Wang YD et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 2013; 495(442): 467\u2013473. doi:10.1038\/nature11922.","DOI":"10.1038\/nature11922"},{"key":"e_1_3_1_55_2","doi-asserted-by":"crossref","unstructured":"Finch N Carrasquillo MM Baker M et al. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 2011; 76(5): 467\u2013474. doi:10.1212\/WNL.0b013e31820a0e3b.","DOI":"10.1212\/WNL.0b013e31820a0e3b"},{"key":"e_1_3_1_56_2","doi-asserted-by":"crossref","unstructured":"Rademakers R Neumann M Mackenzie IR. Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol 2012; 8(8): 423\u2013434. doi:10.1038\/nrneurol.2012.117.","DOI":"10.1038\/nrneurol.2012.117"},{"key":"e_1_3_1_57_2","doi-asserted-by":"crossref","unstructured":"Bigio EH. Making the diagnosis of frontotemporal lobar degeneration. Arch Pathol Lab Med 2013; 137(3): 314\u2013325. doi:10.5858\/arpa.2012-0075-RA.","DOI":"10.5858\/arpa.2012-0075-RA"},{"key":"e_1_3_1_58_2","doi-asserted-by":"crossref","unstructured":"Neumann M Tolnay M Mackenzie IR. The molecular basis of frontotemporal dementia. Expert Rev Mol Med 2009; 11: e23. doi:10.1017\/S1462399409001136.","DOI":"10.1017\/S1462399409001136"},{"key":"e_1_3_1_59_2","doi-asserted-by":"crossref","unstructured":"Seeley WW Carlin DA Allman JM et al. Early frontotemporal dementia targets neurons unique to apes and humans. Ann Neurol 2006; 60(6): 660\u2013667. doi:10.1002\/ana.21055.","DOI":"10.1002\/ana.21055"},{"key":"e_1_3_1_60_2","doi-asserted-by":"crossref","unstructured":"Grossman M Farmer J Leight S et al. Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer\u2019s disease. Ann Neurol 2005; 57(5): 721\u2013729. doi:10.1002\/ana.20477.","DOI":"10.1002\/ana.20477"},{"key":"e_1_3_1_61_2","doi-asserted-by":"crossref","unstructured":"Nicholson AM Finch NA Thomas CS et al. Progranulin protein levels are differently regulated in plasma and CSF. Neurology 2014; 82(21): 1871\u20131878. doi:10.1212\/WNL.0000000000000445.","DOI":"10.1212\/WNL.0000000000000445"},{"key":"e_1_3_1_63_2","unstructured":"FRONTIER: Frontotemporal Dementia Research Group. Frontotemporal dementia rating scale (FRS)-download. www.ftdrg.org\/ace-r-download\/frontotemporal-dementia-rating-scale-frs-download\/. Accessed February 1 2016."},{"key":"e_1_3_1_65_2","doi-asserted-by":"crossref","unstructured":"Shinagawa S Nakajima S Plitman E et al. Non-pharmacological management for patients with frontotemporal dementia: a systematic review. J Alzheimers Dis 2015; 45(1): 283\u2013293. doi:10.3233\/JAD-142109.","DOI":"10.3233\/JAD-142109"},{"key":"e_1_3_1_66_2","doi-asserted-by":"crossref","unstructured":"Mendez MF Lauterbach EC Sampson SM. ANPA Committee on Research. An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci 2008; 20(2): 130\u2013149. doi:10.1176\/appi.neuropsych.20.2.130.","DOI":"10.1176\/appi.neuropsych.20.2.130"},{"key":"e_1_3_1_67_2","unstructured":"Association for Frontotemproal Degeneration. Changes in behavior. www.theaftd.org\/wp-content\/uploads\/2011\/09\/Packet-Changes-in-behavior-chart.pdf. Published 2009. Accessed February 1 2016."},{"key":"e_1_3_1_68_2","doi-asserted-by":"crossref","unstructured":"Tsai RM Boxer AL. Treatment of frontotemporal dementia. Curr Treat Options Neurol 2014; 16(11): 319. doi:10.1007\/s11940-014-0319-0.","DOI":"10.1007\/s11940-014-0319-0"},{"key":"e_1_3_1_70_2","doi-asserted-by":"crossref","unstructured":"Herrmann N Black SE Chow T et al. Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia. Am J Geriatr Psychiatry 2012; 20(9): 789\u2013797. doi:10.1097\/JGP.0b013e31823033f3.","DOI":"10.1097\/JGP.0b013e31823033f3"},{"key":"e_1_3_1_72_2","doi-asserted-by":"crossref","unstructured":"Lebert F Stekke W Hasenbroekx C Pasquier F. Frontotemporal dementia: a randomised controlled trial with trazodone. Dement Geriatr Cogn Disord 2004; 17(4): 355\u2013359. doi:10.1159\/000077171.","DOI":"10.1159\/000077171"},{"key":"e_1_3_1_76_2","doi-asserted-by":"crossref","unstructured":"Ikeda M Shigenobu K Fukuhara R et al. Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients. Dement Geriatr Cogn Disord 2004; 17(3): 117\u2013121. doi:10.1159\/000076343.","DOI":"10.1159\/000076343"},{"key":"e_1_3_1_77_2","doi-asserted-by":"crossref","unstructured":"Boxer AL Knopman DS Kaufer DI et al. Memantine in patients with frontotemporal lobar degeneration: a multicentre randomised double-blind placebo-controlled trial. Lancet Neurol 2013; 12(2): 149\u2013156. doi:10.1016\/S1474-4422(12)70320-4.","DOI":"10.1016\/S1474-4422(12)70320-4"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1212\/CON.0000000000000300","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:00:11Z","timestamp":1752156011000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1212\/CON.0000000000000300"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000300","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}